Aim and Scope

The International Journal of Pharmaceutical Research and Allied Sciences (IJPRAS) [ISSN: 2277-3657] is a comprehensive, open-access scholarly journal that follows a double-blind peer-review process.

Aim

The journal aims to advance theoretical, experimental, computational, and clinical knowledge in pharmaceutical research and allied sciences by publishing high-quality original research articles, reviews, and other scholarly contributions. It seeks to connect fundamental discoveries with pharmaceutical development, clinical application, and patient-centered care while promoting interdisciplinary and translational research across the pharmaceutical sciences.

Scope

The journal welcomes original research and review articles in the following areas:

1.      Pharmaceutical Sciences and Drug Development

o    Pharmaceutics, formulation science, and advanced pharmaceutical formulations, including solid, topical, parenteral, and novel drug delivery systems

o    Nano- and targeted drug delivery systems, biomaterials, and pharmaceutical nanotechnology

o    Medicinal chemistry, pharmacognosy, natural products, and drug discovery

o    Pharmacology, toxicology, pharmacovigilance, and drug safety

o    Pharmaceutical analysis, analytical chemistry, pharmaceutical technology, manufacturing, quality assurance, and regulatory affairs

o    Biopharmaceutics, clinical pharmacokinetics, pharmacodynamics, and PK/PD modelling

o    Biopharmaceuticals, biosimilars, and pharmaceutical biotechnology

2.      Computational and Precision Pharmaceutical Sciences

o    Pharmacoinformatics, cheminformatics, bioinformatics, computational biology, and computer-aided drug design

o    Quantitative structure–activity relationship (QSAR) modelling and molecular modelling

o    Molecular dynamics simulations, molecular docking, virtual screening, and related computational methods

o    Pharmacogenomics, precision pharmacotherapy, personalized medicine, and biomarker-guided treatment

o    Artificial intelligence, machine learning, and data-driven approaches relevant to drug discovery, development, and therapeutic decision-making

3.      Allied Biomedical and Health Sciences

o    Biotechnology, microbiology, biochemistry, molecular biology, pathology, and neurosciences

o    Biomaterial sciences, tissue engineering, and biomedical applications relevant to pharmaceuticals

o    Clinical pharmacy, pharmacotherapy, pharmacoepidemiology, and pharmaceutical care

o    Health outcomes research, pharmacoeconomics, real-world evidence, and evidence-based medicine

4.      Translational and Interdisciplinary Research

o    Translational pharmaceutical research connecting laboratory discoveries with preclinical studies, clinical development, and therapeutic applications

o    Interdisciplinary approaches to drug discovery, formulation development, delivery, evaluation, and clinical use

o    Emerging technologies and innovative methods in pharmaceutical and biomedical research

o    Sustainable pharmaceutical manufacturing, green chemistry, and environmental biotechnology

o    Bioremediation, pharmaceutical waste management, and environmental studies with direct relevance to pharmaceuticals

Issue 3 Volume 15 (2026)